AS101

DRUG3 trials

Sponsors

Rabin Medical Center, BioMAS Ltd

Conditions

Acute Myeloid LeukemiaAlopeciaChemotherapy Induced ThrombocytopeniaMyelodysplastic Syndrome

Phase 2

Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women

Rabin Medical CenterAlopecia

Target: 40Updated: 2007-01-04

Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients

TerminatedNCT00926354

BioMAS LtdChemotherapy Induced Thrombocytopenia

Start: 2009-08-31End: 2010-08-31Target: 40Updated: 2011-06-21

Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients

SuspendedNCT01010373

BioMAS LtdAcute Myeloid Leukemia, Myelodysplastic Syndrome

Start: 2015-01-31End: 2016-01-31Target: 12Updated: 2015-02-10